Archives de pediatrie : organe officiel de la Societe francaise de pediatrie · 2026
Posterior reversible encephalopathy syndrome in children after hematopoietic stem cell and solid organ transplantation: a single-center study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Cacqueray Noémie, Roux Charles-Joris, Levy Raphaël, Sarda Eugénie, Kossorotoff Manoëlle, Lacaille Florence, Boyer Olivia, Houyel Lucile, Vedrenne-Cloquet Meryl, Castelle Martin, Neven Bénédicte, Moshous Despina, Boussard Charlotte
Аннотация
BACKGROUND: Posterior Reversible Encephalopathy Syndrome (PRES) is an acute neurological syndrome characterized by clinical and radiologic features that can occur in children under specific circumstances. Solid Organ Transplantation (SOT) and Hematopoietic Stem Cell Transplantation (HSCT) are the most commonly reported underlying conditions in children, although they have been studied separately and in small series.
OBJECTIVE: This study aimed to compare the characteristics of PRES in children following HSCT and SOT.
METHODS AND SETTINGS: We conducted a retrospective single-center study of children diagnosed with PRES after transplantation between 2007 and 2019 based on a review of local transplant databases. Neuroradiologists reviewed all brain magnetic resonance imaging (MRI) to confirm diagnoses. Clinical presentation, imaging findings, risk factors, and outcomes were compared between children after HSCT and SOT.
RESULTS: Among 548 HSCT and 556 SOT recipients, 33 PRES cases were initially suspected. After imaging review, 12 cases were excluded. Finally, nine cases of PRES following HSCT (median age 7.6 years, 6 males) and 12 following SOT (liver, kidney, and heart transplants, median age 8.9 years, 7 males) were included. PRES was a rare complication, occurring in 2% of patients undergoing HSCT and SOT (p= 0.66). Clinical presentation was similar in both groups, mainly with seizures (n=20, 95%). Hypertension and transplantation-related complications promoting endothelial damage were common in both groups. MRI showed typical posterior brain lesions in all patients, but also abnormal anterior regions in 19 (91%) patients and positive diffusion restriction in ten (48%). PRES was a severe complication, with frequent intensive care unit (ICU) admission (n=13, 62%).
CONCLUSION: PRES is a rare but severe complication in children after transplantation, with a higher incidence and severity than previously reported. Our findings suggest a key role of endothelial dysfunction. Early recognition of risk factors and careful interpretation of MRI are crucial for timely diagnosis and management.
OBJECTIVE: This study aimed to compare the characteristics of PRES in children following HSCT and SOT.
METHODS AND SETTINGS: We conducted a retrospective single-center study of children diagnosed with PRES after transplantation between 2007 and 2019 based on a review of local transplant databases. Neuroradiologists reviewed all brain magnetic resonance imaging (MRI) to confirm diagnoses. Clinical presentation, imaging findings, risk factors, and outcomes were compared between children after HSCT and SOT.
RESULTS: Among 548 HSCT and 556 SOT recipients, 33 PRES cases were initially suspected. After imaging review, 12 cases were excluded. Finally, nine cases of PRES following HSCT (median age 7.6 years, 6 males) and 12 following SOT (liver, kidney, and heart transplants, median age 8.9 years, 7 males) were included. PRES was a rare complication, occurring in 2% of patients undergoing HSCT and SOT (p= 0.66). Clinical presentation was similar in both groups, mainly with seizures (n=20, 95%). Hypertension and transplantation-related complications promoting endothelial damage were common in both groups. MRI showed typical posterior brain lesions in all patients, but also abnormal anterior regions in 19 (91%) patients and positive diffusion restriction in ten (48%). PRES was a severe complication, with frequent intensive care unit (ICU) admission (n=13, 62%).
CONCLUSION: PRES is a rare but severe complication in children after transplantation, with a higher incidence and severity than previously reported. Our findings suggest a key role of endothelial dysfunction. Early recognition of risk factors and careful interpretation of MRI are crucial for timely diagnosis and management.